1. Survey of 550 adults found a 46 percent reduction in constant food thoughts after starting Wegovy.
2. 64 percent of participants reported improved mental well being, suggesting benefits beyond weight loss.
A survey of 550 adults presented at the European Association for the Study of Diabetes reported that constant food thoughts dropped from 62 percent to 16 percent after treatment with Wegovy. This represents a relative reduction of 46 percent. In the same study, 64 percent of participants said their mental well being improved. Novo Nordisk, which generated more than five billion dollars in Wegovy sales last year, is highlighting these findings to frame obesity treatment as both metabolic and psychological. Most respondents were middle aged women, so further studies will be needed to confirm whether the benefits extend to more diverse populations. Patients reported less “food noise,” a term increasingly used to describe intrusive mental preoccupation with eating. For physicians, the survey provides a useful counseling point: adherence may improve not just because of weight reduction but because of reduced cognitive burden. While observational data are not as rigorous as randomized trials, quality-of-life outcomes often resonate strongly with patients. These findings also align with the growing view that obesity is a multifaceted disease involving neurobiology as much as metabolism. Long-term studies will determine whether these mental health gains persist. For now, the results add a compelling narrative for patients struggling with both obesity and constant intrusive food thoughts.
Image: PD
©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.